Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Jiangsu Apon Medical Technology

Guan Jifeng, director of Aipeng Medical (300753.SZ), plans to reduce his holdings by no more than 263,900 shares

  • Post date May 14, 2022 — 12:03 Post Lock Login to View

Read More

Aipeng Medical (300753): Legal Opinion of DeHeng Shanghai Law Firm on the Witness of Aipeng Medical's First Extraordinary General Meeting of Shareholders in 2022- CFi.CN Zhongcai Network

  • Post date May 13, 2022 — 22:07 Post Lock Login to View

Read More

Aipeng Medical (300753): Resolution of the First Extraordinary General Meeting of Shareholders in 2022- CFi.CN Zhongcai Network

  • Post date May 13, 2022 — 22:07 Post Lock Login to View

Read More

Aipeng Medical (300753): Pre-Disclosure Announcement on Reduction of Shares by Some Directors- CFi.CN Zhongcai Network

  • Post date May 13, 2022 — 22:07 Post Lock Login to View

Read More

Aipeng Medical: Director Guan Jifeng plans to reduce his holdings by no more than about 260,000 shares_Shenzhen Hotline

  • Post date May 13, 2022 — 22:06 Post Lock Login to View

Read More

Aipeng Medical (300753.SZ): Director Guan Jifeng plans to reduce his holdings by no more than 263,949 shares_Stock Information_Market Gold Online

  • Post date May 13, 2022 — 21:47 Post Lock Login to View

Read More

Aipeng Medical: Director Guan Jifeng plans to reduce his holdings by no more than about 260,000 shares jqknews

  • Post date May 13, 2022 — 21:36 Post Lock Login to View

Read More

Notice! Aipeng Medical: Director Guan Jifeng plans to reduce his holdings by no more than about 260,000 shares

  • Post date May 13, 2022 — 21:33 Post Lock Login to View

Read More

Guan Jifeng, director of Aipeng Medical (300753.SZ), plans to reduce his holdings by no more than 263,900 shares

  • Post date May 13, 2022 — 21:31 Post Lock Login to View

Read More

Guan Jifeng, director of Aipeng Medical (300753.SZ), plans to reduce his holdings by no more than 263,900 shares

  • Post date May 13, 2022 — 21:31 Post Lock Login to View

Read More

Aipeng Medical: The company will continue to deepen the pain management and nasal care track

  • Post date May 6, 2022 — 18:25 Post Lock Login to View

Read More

Live Preview 2022 M&A Prospects of the Medical Device Industry

  • Post date April 26, 2022 — 23:43 Post Lock Login to View

Read More

Live Preview 2022 M&A Prospects of the Medical Device Industry

  • Post date April 26, 2022 — 00:26 Post Lock Login to View

Read More

Live Preview 2022 M&A Prospects of the Medical Device Industry

  • Post date April 22, 2022 — 05:50 Post Lock Login to View

Read More

Aipeng Medical: The company's R&D headquarters, nasal cavity and upper airway management operations are all located in Shanghai, e-commerce operations in Hangzhou, production base in Rudong

  • Post date April 3, 2022 — 11:05 Post Lock Login to View

Read More

Aipeng Medical: The company's R&D headquarters, nasal cavity and upper airway management operations are all located in Shanghai, e-commerce operations, and Hangzhou production base in Rudong

  • Post date April 3, 2022 — 11:05 Post Lock Login to View

Read More

Aipeng Medical: The company's R&D headquarters, nasal cavity and upper airway management operations are located in Shanghai, e-commerce operations are located in Hangzhou, and production bases are located in Rudong Meijing.com

  • Post date April 3, 2022 — 11:02 Post Lock Login to View

Read More

  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.